NCT06422351Phase 2Suspended

Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency

Study sponsor: Rocket Pharmaceuticals Inc. · RCKT

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2029-01Estimated

Enrollment · participants10Estimated

Source updated2026-04-16Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-04-16 · 2 fields changed

Primary completion date changed

− Before

~~Nov 2026~~

+ After

Jan 2029

Recruitment status changed

− Before

~~Not yet recruiting~~

+ After

Suspended

Check registry source